Investing in the future of health: Singapore’s growing longevity sector

Singapore's healthcare landscape is witnessing a surge in longevity-focused services. At 72, Ivan Low has managed to reduce his biological age, which is a measure of how much damage has occurred to the body's cells over time. This age is influenced by genetic factors, lifestyle choices and physical environment. Low's journey to improve his health included adding exercises like spinning and dietary adjustments to his routine.

This shift towards 'healthy longevity medicine' is grounded in geroscience, a field that studies the biological mechanisms of ageing. Clinicians aim to delay age-related decline by using advanced diagnostics like biological age monitoring, microbiome analysis, and functional measures such as cardiorespiratory fitness tests. These diagnostics are coupled with personalized lifestyle interventions like targeted exercise regimes.

The trend of healthy longevity is not limited to public institutions like Alexandra Hospital. Private healthcare groups and commercial players are also jumping on the bandwagon. In early 2026, Raffles Medical Group launched a healthy longevity clinic, followed by IHH Healthcare's Healthspan, which offers biological age testing across its Parkway Shenton clinics.

These services, while still emerging, are gaining popularity among Singaporeans. Many are drawn to the idea of knowing their biological age, which gives them a more precise understanding of their health and potential longevity. While standard screening tests are primarily used to detect diseases, longevity diagnostics focus on biological ageing, organ system health, and functional resilience.

The most popular test in Singapore is IHH Healthcare's AgeQ, which uses seven key blood biomarkers to estimate how fast one's cells and organ systems are ageing.